Free Trial

Amalgamated Bank Reduces Position in Perrigo Company plc (NYSE:PRGO)

Perrigo logo with Medical background

Amalgamated Bank trimmed its holdings in shares of Perrigo Company plc (NYSE:PRGO - Free Report) by 25.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 63,564 shares of the company's stock after selling 21,786 shares during the period. Amalgamated Bank's holdings in Perrigo were worth $1,667,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in PRGO. Beach Investment Counsel Inc. PA bought a new stake in shares of Perrigo during the 2nd quarter worth $72,000. Voisard Asset Management Group Inc. raised its stake in shares of Perrigo by 520.0% during the 2nd quarter. Voisard Asset Management Group Inc. now owns 4,650 shares of the company's stock worth $119,000 after purchasing an additional 3,900 shares during the period. CWM LLC raised its stake in shares of Perrigo by 877.0% during the 2nd quarter. CWM LLC now owns 8,197 shares of the company's stock worth $210,000 after purchasing an additional 7,358 shares during the period. Sanctuary Advisors LLC bought a new stake in shares of Perrigo during the 2nd quarter worth $213,000. Finally, nVerses Capital LLC bought a new stake in shares of Perrigo during the 3rd quarter worth $262,000. 95.91% of the stock is currently owned by institutional investors.

Insider Transactions at Perrigo

In other news, Director Katherine C. Doyle sold 8,954 shares of the stock in a transaction on Friday, September 13th. The shares were sold at an average price of $27.30, for a total value of $244,444.20. Following the transaction, the director now owns 6,009 shares of the company's stock, valued at $164,045.70. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In related news, EVP Svend Andersen sold 28,300 shares of the business's stock in a transaction that occurred on Tuesday, August 20th. The stock was sold at an average price of $27.75, for a total value of $785,325.00. Following the completion of the sale, the executive vice president now owns 73,553 shares in the company, valued at $2,041,095.75. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Katherine C. Doyle sold 8,954 shares of the stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $27.30, for a total transaction of $244,444.20. Following the transaction, the director now owns 6,009 shares in the company, valued at $164,045.70. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 50,254 shares of company stock valued at $1,411,969. 0.70% of the stock is owned by corporate insiders.

Perrigo Trading Up 1.2 %

Shares of PRGO traded up $0.31 during midday trading on Wednesday, hitting $26.68. 899,925 shares of the company traded hands, compared to its average volume of 1,621,152. The stock has a 50-day moving average of $26.04 and a 200-day moving average of $27.38. Perrigo Company plc has a one year low of $23.89 and a one year high of $34.60. The company has a current ratio of 2.56, a quick ratio of 1.77 and a debt-to-equity ratio of 0.94.

Perrigo (NYSE:PRGO - Get Free Report) last posted its earnings results on Wednesday, November 6th. The company reported $0.81 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.81. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. The business had revenue of $1.09 billion for the quarter, compared to analysts' expectations of $1.12 billion. During the same period in the prior year, the company posted $0.64 EPS. The business's revenue for the quarter was down 3.2% compared to the same quarter last year. As a group, research analysts anticipate that Perrigo Company plc will post 2.56 EPS for the current fiscal year.

Perrigo Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Friday, November 29th will be paid a $0.276 dividend. The ex-dividend date of this dividend is Friday, November 29th. This represents a $1.10 dividend on an annualized basis and a yield of 4.14%. Perrigo's dividend payout ratio is currently -94.02%.

Analyst Ratings Changes

A number of brokerages recently issued reports on PRGO. StockNews.com upgraded Perrigo from a "hold" rating to a "buy" rating in a research note on Thursday, November 7th. Jefferies Financial Group restated a "hold" rating and issued a $30.00 price objective (down from $50.00) on shares of Perrigo in a research note on Monday, September 23rd. Finally, Canaccord Genuity Group restated a "buy" rating and issued a $42.00 price objective on shares of Perrigo in a research note on Monday, September 30th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $37.00.

View Our Latest Research Report on PRGO

About Perrigo

(Free Report)

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

Featured Articles

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Should you invest $1,000 in Perrigo right now?

Before you consider Perrigo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Perrigo wasn't on the list.

While Perrigo currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Whitestone REIT is Outperforming in 2024: 35% Growth & Monthly Dividends
Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors
Nintendo Stock: Buy Before the 2025 Switch Platform Hits!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines